Huiliang Cui

462 total citations
13 papers, 233 citations indexed

About

Huiliang Cui is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Computer Networks and Communications. According to data from OpenAlex, Huiliang Cui has authored 13 papers receiving a total of 233 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cardiology and Cardiovascular Medicine, 6 papers in Endocrinology, Diabetes and Metabolism and 2 papers in Computer Networks and Communications. Recurrent topics in Huiliang Cui's work include Cardiovascular Function and Risk Factors (7 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (2 papers). Huiliang Cui is often cited by papers focused on Cardiovascular Function and Risk Factors (7 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (2 papers). Huiliang Cui collaborates with scholars based in China and Bangladesh. Huiliang Cui's co-authors include Jianmin Yang, Zhenguo Wu, Wencheng Zhang, Li Liu, Weiwei Wang, Li Liu, Dejin Zang, Li Liu, Jie Peng and Wei Li and has published in prestigious journals such as Scientific Reports, European Heart Journal and Cell Death and Differentiation.

In The Last Decade

Huiliang Cui

10 papers receiving 232 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huiliang Cui China 7 149 132 96 30 25 13 233
Zhenguo Wu China 9 170 1.1× 165 1.3× 123 1.3× 33 1.1× 36 1.4× 16 306
Geng Liu China 7 137 0.9× 119 0.9× 76 0.8× 49 1.6× 36 1.4× 16 243
Libin Ren China 5 166 1.1× 188 1.4× 90 0.9× 46 1.5× 58 2.3× 6 294
Najmusaqib Khan Niazi Pakistan 3 163 1.1× 101 0.8× 111 1.2× 38 1.3× 18 0.7× 7 276
Yitian Qi China 6 126 0.8× 88 0.7× 112 1.2× 27 0.9× 10 0.4× 13 243
Yifen Lin China 8 81 0.5× 152 1.2× 44 0.5× 37 1.2× 23 0.9× 29 245
Haozhe Cui China 7 117 0.8× 87 0.7× 109 1.1× 32 1.1× 9 0.4× 20 225
Yukun Zhao China 5 99 0.7× 71 0.5× 90 0.9× 37 1.2× 9 0.4× 6 184
Marcel T. Ferreira Brazil 9 135 0.9× 258 2.0× 47 0.5× 52 1.7× 33 1.3× 10 367
Muhammad Sabbah Denmark 9 61 0.4× 95 0.7× 37 0.4× 50 1.7× 41 1.6× 16 190

Countries citing papers authored by Huiliang Cui

Since Specialization
Citations

This map shows the geographic impact of Huiliang Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huiliang Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huiliang Cui more than expected).

Fields of papers citing papers by Huiliang Cui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huiliang Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huiliang Cui. The network helps show where Huiliang Cui may publish in the future.

Co-authorship network of co-authors of Huiliang Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Huiliang Cui. A scholar is included among the top collaborators of Huiliang Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huiliang Cui. Huiliang Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Lu, Hanlin, Xin Huang, Chang Ma, et al.. (2025). Taurochenodeoxycholic acid alleviates obesity-induced endothelial dysfunction. European Heart Journal. 47(10). 1221–1238. 2 indexed citations
2.
Cui, Huiliang, et al.. (2025). Research on insider threat detection based on personalized federated learning and behavior log analysis. Scientific Reports. 15(1). 19214–19214.
3.
Liu, Shanshan, et al.. (2025). Development and Validation of a Nomogram-Based Risk Prediction Model for Diabetic Retinopathy in Elderly Adults with Type 2 Diabetes Mellitus. Diabetes Metabolic Syndrome and Obesity. Volume 18. 2509–2523.
4.
Cui, Huiliang, Hanlin Lu, Cheng Cheng, et al.. (2025). Macrophage junctional adhesion molecule-like (JAML) protein promotes NLRP3 inflammasome activation in the development of atherosclerosis. Cell Death and Differentiation. 32(10). 1763–1776. 2 indexed citations
5.
Cui, Huiliang, et al.. (2025). Daily insider threat detection with hybrid TCN transformer architecture. Scientific Reports. 15(1). 28590–28590.
7.
Liu, Li, Zhenguo Wu, Huiliang Cui, et al.. (2024). Comparison of seven surrogate insulin resistance indexes for prediction of incident coronary heart disease risk: a 10-year prospective cohort study. Frontiers in Endocrinology. 15. 1290226–1290226. 25 indexed citations
9.
Cheng, Cheng, Wei Fang, Zhenguo Wu, et al.. (2023). Reduced peak expiratory flow predicts increased risk of cardiovascular disease: A 10-year prospective cohort study in Eastern China. Respiratory Medicine and Research. 83. 100988–100988. 1 indexed citations
10.
Wu, Zhenguo, Huiliang Cui, Wei Li, et al.. (2022). Comparison of three non-insulin-based insulin resistance indexes in predicting the presence and severity of coronary artery disease. Frontiers in Cardiovascular Medicine. 9. 918359–918359. 36 indexed citations
11.
Wu, Zhenguo, Li Liu, Weiwei Wang, et al.. (2022). Triglyceride-glucose index in the prediction of adverse cardiovascular events in patients with premature coronary artery disease: a retrospective cohort study. Cardiovascular Diabetology. 21(1). 142–142. 72 indexed citations
12.
Cui, Huiliang, et al.. (2022). The impact of the metabolic score for insulin resistance on cardiovascular disease: a 10-year follow-up cohort study. Journal of Endocrinological Investigation. 46(3). 523–533. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026